Vasundhara Rasayans P/B Ratio
Vasundhara Rasayans (VRL) P/B ratio is 1.13 (Moderate), book value per share ₹136.67 vs Healthcare average P/B of -0.01 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see VRL stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
VRL P/B Ratio — Valuation Insights & Book Value Analysis
Vasundhara Rasayans price-to-book ratio interpretation, valuation status and historical context — current P/B 1.13 (Moderate). Explore VRL investment value to estimate fundamental worth using multiple valuation models.
- Current PB is 39.0% below historical average
- Trading at premium to sector average PB of -0.01
Vasundhara Rasayans P/B Ratio Historical Trend
VRL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read VRL dividend payout details for the complete payout history and dividend yield track record.
VRL Historical P/B Ratio — Book Value Per Share & Year-End Price
Vasundhara Rasayans annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.15 | ₹136.67 | ₹157.15 | ₹41 | Moderate |
| 2025 | 1.42 | ₹120.0 | ₹170.10 | ₹36 | Moderate |
| 2024 | 2.72 | ₹106.67 | ₹290.50 | ₹32 | Moderate |
| 2023 | 2.19 | ₹90.0 | ₹197.50 | ₹27 | Moderate |
| 2022 | 1.78 | ₹73.33 | ₹130.85 | ₹22 | Moderate |
VRL vs Healthcare Peers — P/B Ratio Comparison
Vasundhara Rasayans P/B 1.13 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |